by admin | Nov 28, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Emily Mullin – Wired – It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder. It’s finally being infused into patients. Called Casgevy, the gene-editing treatment is for people with...
by admin | Nov 27, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By The Broad Stem Cell Research Center – Technology Networks – Researchers have uncovered an unexpected role for the molecule netrin1 in organizing the developing spinal cord. Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem...
by admin | Nov 26, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Andis Robeznieks – American Medical Association – It is critically important to make health IT accessible for all and to achieve equitable adoption among aging patients, people with hearing and eyesight impairment, as well as those who live in...
by admin | Nov 25, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Imma Perfetto – Cosmos – An Australian researcher has been awarded $60,000 to build more complex models of the human lung, with the hope to discover new therapies for respiratory diseases. Dr Rhiannon Werder, team leader at the Murdoch Children’s...
by admin | Nov 22, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Frank Vinluan – MedCity News – Autolus Therapeutics’ Aucatzyl is now FDA approved for treating advanced cases of B-cell precursor acute lymphoblastic leukemia. While it goes after the same target as Gilead Sciences’ Tecartus, Autolus engineered its CAR...
